Differences in primary and secondary stroke prevention strategies for Chinese men and women

This study aimed to explore whether stroke prevention strategies differ for men and women. Data used were from China Kadoorie Biobank. According to the China-PAR Project model, a predicted 10-year stroke risk of ≥7% is defined as a high stroke risk. The effects of risk factor control and medication...

Full description

Bibliographic Details
Main Authors: Zenghua Xie, Xu Guo, Liyuan Han, Xin Wang, Qianqian Yan, Chang Shu, Zhenyi Fan, Miaomiao Zhao
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Preventive Medicine Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211335523001109
_version_ 1797827804835872768
author Zenghua Xie
Xu Guo
Liyuan Han
Xin Wang
Qianqian Yan
Chang Shu
Zhenyi Fan
Miaomiao Zhao
author_facet Zenghua Xie
Xu Guo
Liyuan Han
Xin Wang
Qianqian Yan
Chang Shu
Zhenyi Fan
Miaomiao Zhao
author_sort Zenghua Xie
collection DOAJ
description This study aimed to explore whether stroke prevention strategies differ for men and women. Data used were from China Kadoorie Biobank. According to the China-PAR Project model, a predicted 10-year stroke risk of ≥7% is defined as a high stroke risk. The effects of risk factor control and medication use as primary and secondary stroke prevention strategies were assessed, respectively. Logistic regression models were used to assess the sex-specific differences in the primary and secondary stroke prevention practices. Of the 512,715 participants (59.0% women), 218,972 (57.4% women) had a high risk of stroke and 8884 (44.7% women) had an established stroke. Of high-risk participants, women were considerably less likely than men to receive antiplatelets (odds ratio [OR], 0.80; [95% confidence interval, CI, 0.72–0.89]), antihypertensives (0.46[0.44–0.48]), and antidiabetics (0.65[0.60–0.70]). Meanwhile, stroke women were significantly less likely to receive antiplatelets (0.75[0.65–0.85]) but more likely to receive antidiabetics (1.56 [1.34–1.82]) than their male counterparts. Besides, differences were found in risk factor control between women and men. Sex-specific differences in stroke prevention strategies are prevalent in China. Effective prevention requires the implementation of better overall nationwide strategies and special emphasis on women.
first_indexed 2024-04-09T12:54:14Z
format Article
id doaj.art-d13cd0105d3e4c1f93ee30dda896af2a
institution Directory Open Access Journal
issn 2211-3355
language English
last_indexed 2024-04-09T12:54:14Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Preventive Medicine Reports
spelling doaj.art-d13cd0105d3e4c1f93ee30dda896af2a2023-05-14T04:28:47ZengElsevierPreventive Medicine Reports2211-33552023-06-0133102219Differences in primary and secondary stroke prevention strategies for Chinese men and womenZenghua Xie0Xu Guo1Liyuan Han2Xin Wang3Qianqian Yan4Chang Shu5Zhenyi Fan6Miaomiao Zhao7Department of Neurology, Beilun District People’s Hospital, Ningbo, Zhejiang, ChinaDepartment of Rehabilitation Medicine, Hwa Mei Hospital, University of the Chinese Academy of Sciences, Ningbo, Zhejiang, ChinaHwa Mei Hospital, Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China; Department of Global Health, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, ChinaDepartment of Neurology, Beilun District People’s Hospital, Ningbo, Zhejiang, ChinaHwa Mei Hospital, Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China; Department of Global Health, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, ChinaTianjin Cerebral Vascular and Neural Degenerative Disease Key Laboratory, Tianjin Neurosurgery Institute, Tianjin Huanhu Hospital, Tianjin, ChinaDepartment of Neurology, Hwa Mei Hospital, University of Chinese Academy of Science, Ningbo, Zhejiang, China; Corresponding authors.Department of Health Management, School of Public Health, Nantong University, Nantong, Jiangsu, China; Corresponding authors.This study aimed to explore whether stroke prevention strategies differ for men and women. Data used were from China Kadoorie Biobank. According to the China-PAR Project model, a predicted 10-year stroke risk of ≥7% is defined as a high stroke risk. The effects of risk factor control and medication use as primary and secondary stroke prevention strategies were assessed, respectively. Logistic regression models were used to assess the sex-specific differences in the primary and secondary stroke prevention practices. Of the 512,715 participants (59.0% women), 218,972 (57.4% women) had a high risk of stroke and 8884 (44.7% women) had an established stroke. Of high-risk participants, women were considerably less likely than men to receive antiplatelets (odds ratio [OR], 0.80; [95% confidence interval, CI, 0.72–0.89]), antihypertensives (0.46[0.44–0.48]), and antidiabetics (0.65[0.60–0.70]). Meanwhile, stroke women were significantly less likely to receive antiplatelets (0.75[0.65–0.85]) but more likely to receive antidiabetics (1.56 [1.34–1.82]) than their male counterparts. Besides, differences were found in risk factor control between women and men. Sex-specific differences in stroke prevention strategies are prevalent in China. Effective prevention requires the implementation of better overall nationwide strategies and special emphasis on women.http://www.sciencedirect.com/science/article/pii/S2211335523001109Stroke preventionMedication useRisk factor controlSex-specific differencesChina Kadoorie Biobank
spellingShingle Zenghua Xie
Xu Guo
Liyuan Han
Xin Wang
Qianqian Yan
Chang Shu
Zhenyi Fan
Miaomiao Zhao
Differences in primary and secondary stroke prevention strategies for Chinese men and women
Preventive Medicine Reports
Stroke prevention
Medication use
Risk factor control
Sex-specific differences
China Kadoorie Biobank
title Differences in primary and secondary stroke prevention strategies for Chinese men and women
title_full Differences in primary and secondary stroke prevention strategies for Chinese men and women
title_fullStr Differences in primary and secondary stroke prevention strategies for Chinese men and women
title_full_unstemmed Differences in primary and secondary stroke prevention strategies for Chinese men and women
title_short Differences in primary and secondary stroke prevention strategies for Chinese men and women
title_sort differences in primary and secondary stroke prevention strategies for chinese men and women
topic Stroke prevention
Medication use
Risk factor control
Sex-specific differences
China Kadoorie Biobank
url http://www.sciencedirect.com/science/article/pii/S2211335523001109
work_keys_str_mv AT zenghuaxie differencesinprimaryandsecondarystrokepreventionstrategiesforchinesemenandwomen
AT xuguo differencesinprimaryandsecondarystrokepreventionstrategiesforchinesemenandwomen
AT liyuanhan differencesinprimaryandsecondarystrokepreventionstrategiesforchinesemenandwomen
AT xinwang differencesinprimaryandsecondarystrokepreventionstrategiesforchinesemenandwomen
AT qianqianyan differencesinprimaryandsecondarystrokepreventionstrategiesforchinesemenandwomen
AT changshu differencesinprimaryandsecondarystrokepreventionstrategiesforchinesemenandwomen
AT zhenyifan differencesinprimaryandsecondarystrokepreventionstrategiesforchinesemenandwomen
AT miaomiaozhao differencesinprimaryandsecondarystrokepreventionstrategiesforchinesemenandwomen